Corrigendum: Tofacitinib induction and maintenance therapy in East Asian patients with active ulcerative colitis: Subgroup analyses from three phase 3 multinational studies [Intest Res 16, 2, (2018), 233-245]doi 10.5217/ir.2018.16.2.233

Abstract

In this article, the authors regret an error in the reporting of Inflammatory Bowel Disease Questionnaire (IBDQ) patient-reported outcome data in the manuscript. A data extraction error resulted in incorrect IBDQ data being presented in the publication. The error does not affect the overall conclusions regarding IBDQ as the difference between the corrected and erroneous numbers is, in general, small. The error was specific to IBDQ data; all other data have been reviewed and are correct as originally reported. The error affected the IBDQ total scores at baseline reported in Table 1 of the manuscript, and the IBDQ data reported in Section 3. Patient-Reported Outcomes of the manuscript. The corrected IBDQ data for Table 1 and Section 3. Patient-Reported Outcomes are reported below. The corrigendum does not change the conclusion of the article.